DRUG · Unmapped registry intervention
BP-C1
Find medicine records ·
Find other trials using this name
Clinical trial
Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer
NCT04298333
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedDose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Metastatic Breast Cancerunresolved
Stage IV Breast Cancerunresolved
Interventions
BP-C1DRUG
Sponsors & collaborators
Meabco A/Slead sponsor
Meddoccollaborator
Norwegian University of Life Sciencescollaborator
Meddoc Research Indonesia Ltdcollaborator
Meddoc Research Taiwan Ltdcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04298333 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.